Advancing science and supporting clinicians to improve patient care.
Regeneron is a biotechnology leader focused on turning scientific discovery into meaningful medicines for serious diseases. Grounded in genetics and translational research, the company develops innovations that help improve outcomes across immunology, oncology, ophthalmology, rare conditions, and chronic inflammatory disease. Their mission reflects a simple idea: science in service of patients.
Regeneron.com
Commitment to Healthcare Providers
Regeneron seeks to uncover the underlying drivers of disease and translate discoveries into real-world solutions.
Their work includes:
- Precision-targeted therapeutic development
- Advanced antibody engineering platforms
- Genetic research through Regeneron Genetics Center
- Collaboration with academic, government, and industry partners
Through these efforts, Regeneron strives to accelerate breakthroughs that improve health, enhance quality of life, and expand the future of medicine.
Regeneron.com